Suppr超能文献

合成抗甲状腺药物的作用机制:碘化物氧化过程中的碘络合作用。

The mechanism of action of synthetic antithyroid drugs: iodine complexation during oxidation of iodide.

作者信息

Raby C, Lagorce J F, Jambut-Absil A C, Buxeraud J, Catanzano G

机构信息

Department of Chemical Pharmacy, Faculty of Pharmacy, Limoges, France.

出版信息

Endocrinology. 1990 Mar;126(3):1683-91. doi: 10.1210/endo-126-3-1683.

Abstract

A number of compounds of pharmaceutical importance from a variety of chemical families, including thiocyanates, isothiocyanates, thiourea and derivatives, imidazoles, and various amines, were found to form charge transfer complexes with iodine. Parallel studies were carried out to investigate the actions of these drugs on lactoperoxidase and thyroid activity in vivo in the rat (assays of T3 and T4 and histology of the thyroid gland). The results showed that there was a good correlation between the value of Kc (the formation constant of the iodinated complex) and antithyroid activity in vivo. The higher the electron donor power of the compound, the higher the Kc value and the stronger the action on the thyroid. The results indicated that a number of drugs could have secondary antithyroid activity. Some compounds, such as levamisole, tetramethylthiourea, tetrahydrozoline, phenothiazines, and imipramines, with no action on peroxidase had high Kc values (tetramethylthiourea, 13,825 liters/M) and had strong antithyroid activity in the rat. These results suggest that synthetic antithyroid agents may act either on peroxidase and/or the molecular iodine which may be produced by oxidation of iodides (2I(-)----I2----2I+). It has been shown that oxidation of I- can occur in the absence of thyroglobulin. In the absence of a suitable receptor, significant amounts of I2 may, thus, accumulate. The action of such drugs on molecular iodine may have considerable pharmacological significance.

摘要

人们发现,许多具有药学重要性的化合物,来自各种化学家族,包括硫氰酸盐、异硫氰酸盐、硫脲及其衍生物、咪唑以及各种胺类,都能与碘形成电荷转移络合物。开展了平行研究,以调查这些药物对大鼠体内乳过氧化物酶和甲状腺活性的作用(检测T3和T4以及甲状腺组织学)。结果表明,Kc值(碘化络合物的形成常数)与体内抗甲状腺活性之间存在良好的相关性。化合物的给电子能力越强,Kc值越高,对甲状腺的作用越强。结果表明,一些药物可能具有继发性抗甲状腺活性。一些化合物,如左旋咪唑、四甲基硫脲、四氢唑啉、吩噻嗪类和丙咪嗪类,对过氧化物酶无作用,但Kc值较高(四甲基硫脲,13,825升/摩尔),在大鼠体内具有较强的抗甲状腺活性。这些结果表明,合成抗甲状腺药物可能作用于过氧化物酶和/或由碘化物氧化产生的分子碘(2I(-)→I2→2I+)。已经表明,在没有甲状腺球蛋白的情况下,I-的氧化也可能发生。因此,在没有合适受体的情况下,可能会积累大量的I2。此类药物对分子碘的作用可能具有相当大的药理学意义。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验